|
Dr. Winn-Deen came to Cepheid from Roche Molecular Systems in Pleasanton, CA where she led the genomics business group where her team created the overall market strategy and individual business plans for each of that group's diagnostic products. Her career has included development of clinical chemistry reagents, urinalysis strips, immunoassays, and DNA diagnostics. At Applied Biosystems, Dr. Winn-Deen managed the team developing a DNA diagnostic for cystic fibrosis, and as director of diagnostics R&D at Oncor, Inc. she led the team developing novel DNA-based cancer assays including the first FDA approved test for HER2/neu. While at Celera Genomics she established their high-throughput genotyping laboratory, and then directed their genotyping services business. Dr. Winn-Deen received her B.S. in Chemistry from Lehigh University, her Ph.D. in Chemistry from Boston University, and has over 25 years of experience in diagnostics product development. | 